Yeh-Long Chen

678 total citations
23 papers, 568 citations indexed

About

Yeh-Long Chen is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Yeh-Long Chen has authored 23 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Organic Chemistry and 10 papers in Toxicology. Recurrent topics in Yeh-Long Chen's work include Bioactive Compounds and Antitumor Agents (10 papers), Cancer therapeutics and mechanisms (10 papers) and Synthesis and biological activity (7 papers). Yeh-Long Chen is often cited by papers focused on Bioactive Compounds and Antitumor Agents (10 papers), Cancer therapeutics and mechanisms (10 papers) and Synthesis and biological activity (7 papers). Yeh-Long Chen collaborates with scholars based in Taiwan and United States. Yeh-Long Chen's co-authors include Chih-Hua Tseng, Cherng-Chyi Tzeng, Chia-Ning Yang, Pei‐Jung Lu, Shinne-Ren Lin, Long‐Sen Chang, Jung-Chen Su, Kuei-Li Lin, Hui‐Ling Chen and Hao‐Yi Li and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Yeh-Long Chen

23 papers receiving 559 citations

Peers

Yeh-Long Chen
Anila Dwivedi India
Dimitar Jakimov Serbia
Sotiris S. Nikolaropoulos Greece
Jing Bo Shi China
Yong‐Cheng Ma China
Viswanath Arutla India
Rajesh Kakadiya Taiwan
Halil I. Ciftci Japan
Keith C. Ellis United States
Gülşen Akalın Çiftçi Türkiye
Anila Dwivedi India
Yeh-Long Chen
Citations per year, relative to Yeh-Long Chen Yeh-Long Chen (= 1×) peers Anila Dwivedi

Countries citing papers authored by Yeh-Long Chen

Since Specialization
Citations

This map shows the geographic impact of Yeh-Long Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeh-Long Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeh-Long Chen more than expected).

Fields of papers citing papers by Yeh-Long Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeh-Long Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeh-Long Chen. The network helps show where Yeh-Long Chen may publish in the future.

Co-authorship network of co-authors of Yeh-Long Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yeh-Long Chen. A scholar is included among the top collaborators of Yeh-Long Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeh-Long Chen. Yeh-Long Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Hurng-Wern, Chia‐Yih Wang, Yen‐Chun Chen, et al.. (2020). DFIQ, a Novel Quinoline Derivative, Shows Anticancer Potential by Inducing Apoptosis and Autophagy in NSCLC Cell and In Vivo Zebrafish Xenograft Models. Cancers. 12(5). 1348–1348. 18 indexed citations
2.
Miller, Dannah, Cherng-Chyi Tzeng, Evan T. Keller, et al.. (2018). Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer. Cancer Letters. 436. 96–108. 6 indexed citations
3.
Wu, Chang-Yi, Guanyu Chen, Yang‐Chang Wu, et al.. (2018). Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer. Phytomedicine. 54. 109–119. 14 indexed citations
4.
Chiu, Chien‐Chih, Bing‐Hung Chen, Chih-Hua Tseng, et al.. (2015). BPIQ, a novel synthetic quinoline derivative, inhibits growth and induces mitochondrial apoptosis of lung cancer cells in vitro and in zebrafish xenograft model. BMC Cancer. 15(1). 962–962. 30 indexed citations
5.
Tseng, Chih-Hua, Yu‐Wen Chen, Shyh‐Chyun Yang, et al.. (2015). Discovery of Novel <i>N</i>-alkyl 4-anilinofuro[2,3-<i>b</i>]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers. Anti-Cancer Agents in Medicinal Chemistry. 15(4). 493–500. 3 indexed citations
6.
Yang, Chia-Ning, Sheng‐Yu Ku, Hsin-Wen Chang, et al.. (2014). CFS-1686 Causes Cell Cycle Arrest at Intra-S Phase by Interference of Interaction of Topoisomerase 1 with DNA. PLoS ONE. 9(12). e113832–e113832. 12 indexed citations
7.
Tseng, Chih-Hua, Cherng-Chyi Tzeng, Chien‐Chih Chiu, et al.. (2014). Synthesis and antiproliferative evaluation of 9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinoline-11-one derivatives. Part 4. MedChemComm. 5(7). 937–948. 7 indexed citations
8.
Tseng, Chih-Hua, Cherng-Chyi Tzeng, Pei‐Jung Lu, et al.. (2013). Discovery of indeno[1,2- $$c$$ c ]quinoline derivatives as dual topoisomerases I/II inhibitors: Part 3. Molecular Diversity. 17(4). 781–799. 14 indexed citations
9.
Kao, Chai‐Lin, et al.. (2010). Copper complex of a pyridine-modified poly(amidoamine) dendrimer as a chemical nuclease: synthetic and catalytic study. Nanomedicine Nanotechnology Biology and Medicine. 7(3). 273–276. 15 indexed citations
10.
Lee, Chia-Lin, Hui‐Chun Wang, Da-Wei Chuang, et al.. (2010). First total synthesis of antrocamphin A and its analogs as anti-inflammatory and anti-platelet aggregation agents. Organic & Biomolecular Chemistry. 9(1). 70–73. 21 indexed citations
11.
Lin, Kuei-Li, Jung-Chen Su, Chih-Hua Tseng, et al.. (2010). Naphtho[1,2-b]furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: Involvement of EGF receptor/PI3K/Akt signaling pathway. European Journal of Pharmacology. 636(1-3). 52–58. 30 indexed citations
12.
Lin, Kuei-Li, Jung-Chen Su, Chih-Hua Tseng, et al.. (2010). Naphtho[1,2-b]furan-4,5-dione disrupts Janus kinase-2 and induces apoptosis in breast cancer MDA-MB-231 cells. Toxicology in Vitro. 24(4). 1158–1167. 13 indexed citations
13.
Tseng, Chih-Hua, Cherng-Chyi Tzeng, Pei‐Jung Lu, et al.. (2010). Synthesis and Antiproliferative Evaluation of Certain Indeno[1,2-c]quinoline Derivatives. Part 2. Journal of Medicinal Chemistry. 53(16). 6164–6179. 71 indexed citations
14.
Su, Jung-Chen, Kuei-Li Lin, Chih-Hua Tseng, et al.. (2009). Naphtho[1,2-b]furan-4,5-dione inactivates EGFR and PI3K/Akt signaling pathways in human lung adenocarcinoma A549 cells. Life Sciences. 86(5-6). 207–213. 20 indexed citations
15.
Lee, Chih‐Hung, Wan‐Ping Hu, Chien‐Hui Hong, et al.. (2009). Pyrrolo[2,1-c][1,4]benzodiazepine and indole conjugate (IN6CPBD) has better efficacy and superior safety than the mother compound DC-81 in suppressing the growth of established melanoma in vivo. Chemico-Biological Interactions. 180(3). 360–367. 7 indexed citations
16.
Su, Jung-Chen, Kuei-Li Lin, Chih‐Ming Lu, et al.. (2009). Novel indoloquinoline derivative, IQDMA, induces G2/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation. Life Sciences. 85(13-14). 505–516. 25 indexed citations
17.
Chen, Hui-Ting, et al.. (2009). Pyridoxal 5′-Phosphate Binding in Lysine-Modified PAMAM Dendrimers: A Biomimetic Approach. Organic Letters. 11(16). 3526–3529. 4 indexed citations
18.
Lin, Kuei-Li, Jung-Chen Su, Chih-Hua Tseng, et al.. (2009). Naphtho[1,2-b]furan-4,5-dione induces apoptosis and S-phase arrest of MDA-MB-231 cells through JNK and ERK signaling activation. Toxicology in Vitro. 24(1). 61–70. 34 indexed citations
19.
Tseng, Chih-Hua, Yeh-Long Chen, Pei‐Jung Lu, Chia-Ning Yang, & Cherng-Chyi Tzeng. (2008). Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Bioorganic & Medicinal Chemistry. 16(6). 3153–3162. 108 indexed citations
20.
Lu, Pei‐Jung, et al.. (2005). Synthesis, antiproliferative, and antiplatelet activities of oxime- and methyloxime-containing flavone and isoflavone derivatives. Bioorganic & Medicinal Chemistry. 13(21). 6045–6053. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anila Dwivedi Breakdown of academic impact, for papers by Dimitar Jakimov Breakdown of academic impact, for papers by Sotiris S. Nikolaropoulos Breakdown of academic impact, for papers by Jing Bo Shi Breakdown of academic impact, for papers by Yong‐Cheng Ma Breakdown of academic impact, for papers by Viswanath Arutla Breakdown of academic impact, for papers by Rajesh Kakadiya Breakdown of academic impact, for papers by Halil I. Ciftci Breakdown of academic impact, for papers by Keith C. Ellis Breakdown of academic impact, for papers by Gülşen Akalın Çiftçi
Rankless by CCL
2026